SEC FORM 4
$78,196.44
FILANA THERAPEUTICS, INC. (FLNA)
Purchase of 93,091 shares at $0.84 per share.
Reporting Person Barry Richard · Officer Title President & CEO · Transaction Code P
Traded Sep 28, 2026 · Disclosed Sep 30, 2026
Source: SEC Form 4 · 0001437749-26-031597 · filed 2026-09-30 · View filing →